The multiple actions of the phytomedicine Echinacea in the treatment of colds and flu

Journal of Medicinal Plants Research

Volumn 4, Issue 25, 2010, Pages 2746-2752

  Hudson, James B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anti inflammatory; Antibacterial; Antiviral; Colds; Echinacea; Influenza

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ECHINACEA ANGUSTIFLORA EXTRACT; ECHINACEA PALLIDA EXTRACT; ECHINACEA PURPUREA EXTRACT; ECHINAFORCE; INTERLEUKIN 6; INTERLEUKIN 8; MUCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; BOTANY; COMMON COLD; DRUG MECHANISM; DRUG SYNTHESIS; ECHINACEA; ECHINACEA ANGUSTIFLORA; ECHINACEA PALLIDA; HUMAN; INFLUENZA; NOMENCLATURE; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; PROTEIN SECRETION; RESPIRATORY EPITHELIUM; REVIEW; TISSUE CHARACTERIZATION;

ASTERACEAE; ECHINACEA (ASTERACEAE); HAEMOPHILUS INFLUENZAE; ORTHOMYXOVIRIDAE; RHINOVIRUS; SIMPLEXVIRUS; STREPTOCOCCUS PYOGENES;

EID: 79251584666     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Altamirano-Dimas M, Hudson JB, Cochrane D, Nelson C, Arnason JT (2007). Modulation of immune response gene expression by Echinacea extracts: results of a gene array analysis. Can. J. Physiol. Pharmacol., 85: 1091-1098
2. Altamirano-Dimas M, Sharma M, Hudson JB (2009).Echinacea and anti-inflammatory cytokine responses: Results of a gene and protein array analysis. Pharmac. Biol., 47: 500-508
3. Barnes J, Anderson LA, Gibbons S, Phillipson JD (2005). Echinacea species (Echinacea angustifolia (DC.) Hell. Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench: A review of their chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol., 57: 929-954
4. Binns SE, Livesey JF, Arnason JT, Baum BR (2002). Phytochemical variation in Echinacea from roots and flowerheads of wild and cultivated populations. J. Agric. Food Chem., 50: 3673-3687
5. Binns SE, Hudson J, Merali S, Arnason JT (2002). Antiviral activity of characterized extracts from Echinacea spp (Heliantheae: Asteraceae) against herpes simplex virus (HSV-1). Planta Med., 68: 780-783
6. Burns JJ, Zhao L, Taylor EW, Spelman K (2009). The influence of traditional herbal formulas on cytokine activity. Toxicology doi:1016/j.tox.2009.09.020
7. Cheng PKC, Leung TWC, Ho ECM, Leung PKC, Ng AYY, Lai MYY, Lim WWL (2009). Oseltamivir- and Amantadine-Resistant Influenza viruses A (H1N1). Emerg. Infec. Dis., 15: 966-968
8. Diamond G, Beckloff N, Ryan LK (2008). Host Defense Peptides in the Oral Cavity and the Lung: Similarities and Differences. J. Dent. Res. 87: 915-927
9. Evans SE, Xu Y, Tuvim MJ, Dickey BF (2010). Inducible Innate Resistance of Lung Epithelium to Infection. Annu. Rev. Physiol., 72: 413-435
10. Fedson DS (2009). Confronting the next influenza pandemic with antiinflammatory and immunomodulatory agents: Why they are needed and how they might work. Influenza and other Resp. Viruses, 3: 129-142
11. Gwaltney JM (2002). Clinical significance and pathogenesis of viral respiratory infections. Am. J. Med., 112: 13S-18S.
12. Hudson JB (2009).The use of herbal extracts in the control of influenza. J. Med. Plant Res., 3(13): 1189-1195
13. Hudson J, Towers GHN (1999). Phytomedicines as antivirals. Drugs of the future, 24 (3): 295-320
14. Hudson J, Vimalanathan S, Kang L, Treyvaud Amiguet V, Livesey J, Arnason JT (2005). Characterization of antiviral activities in Echinacea root preparations. Pharmac. Biol., 43: 790-796
15. LeClair EE (2003). Four Reasons to Consider a Novel Class of Innate Immune Molecules in the Oral Epithelium. J. Dent. Res., 82: 944-950.
16. Ludwig S (2009). Targeting cell signaling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J. Antimic. Ther., 64: 1-4.
17. Mosser AG, Vrtis R, Burchell L, Lee WM, Dick CR, Weisshaar E, Bock D, Swenson CR, Cornwell RD, Meyer KC, Jarjour NN, Busse WW, Gern JE (2005). Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Amer. J. Resp. Critical Care Med., 171: 645-651
18. Nickerson CA, Richter EG, Ott CM (2007). Studying Host-Pathogen Interactions in 3-D: Organotypic Models for Infectious Disease and Drug Development. J. Neuroimmune Pharmacol., 2: 26-31
19. Pleschka S, Stein M, Schoop R, Hudson JB (2009). Antiviral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virology J., 6: 197.
20. Roxas M, Jurenka J (2007). Colds and influenza: A review of diagnosis and conventional, botanical, and nutritional considerations. Altern. Med. Rev., 12: 25-48.
21. Schneider S, Reichling J, Stintzing FC, Messerschmidt S, Meyer U, Schnitzler P (2010). Anti-herpetic Properties of Hydroalcoholic Extracts and Pressed Juice from Echinacea pallida. Planta Med., 76: 265-272.
22. See H, Wark P (2008). Innate immune response to viral infection. Paed. Resp. Rev., 9: 243-250.
23. Sharma M, Vohra S, Arnason JT, Hudson JB (2008). Echinacea Extracts Contain Significant and Selective Activities Against Human Pathogenic Bacteria Pharmac. Biol., 46: 111-116
24. Sharma M, Schoop R, Hudson JB (2008). Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters. Phytother. Res., 23: 863-867
25. Sharma M, Anderson SA, Schoop R, Hudson JB (2009). Induction of pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res., 83: 165-170
26. Sharma M, Schoop R, Hudson JB (2009). The Efficacy of Echinacea in a 3-D Tissue Model of Human Airway Epithelium. Phytother. Res., 24: 900-904
27. Sharma S, Anderson SM, Schoop R, Hudson JB (2010). Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce): Dual actions against respiratory bacteria. Phytomedicine, 17: 563-568.
28. Spelman K (2006). Philosophy in Phytopharmacology: Ockam's Razor versus Synergy. J. Herbal Pharmacother., 5: 31-47.
29. Vohra S, Adams D, Hudson JB, Moore JA, Vimalanathan S, Sharma M, Burt A, Lamont E, Lacaze N, Arnason JT, Lee TDG (2009). Selection of Natural Health Products for Clinical Trials: A Preclinical Template. Can. J. Physiol. Pharmacol., 87: 371-378.
30. Vimalanathan S, Kang L, Treyvaud Amiguet V, Livesey J, Arnason JT, Hudson J (2005). Echinacea purpurea Aerial Parts Contain Multiple Antiviral Compounds. Pharmac. Biol., 43: 74-745.
31. Vimalanathan S, Arnason JT, Hudson JB (2009). Anti-inflammatory activities of Echinacea extracts do not correlate with traditional marker components. Pharmac. Biol., 47: 430-435.
32. Wang CY, Staniforth V, Chiao MT, Hou CC, Wu HM, Yeh KC, Chen CH, Hwang PI, Wen TN, Shyur LF, Yang NS (2008). Genomics and proteomics of immune modulatory effects of a butanol fraction of Echinacea purpurea in human dendritic cells. BMC Genomics, 9: 479.